Where to reinvest your Fortescue (ASX:FMG) dividends

It's payday for Fortescue Metals Group Limited (ASX:FMG) shareholders on Wednesday. Here's where you could invest these dividends…

| More on:
Rolled up notes of Australia dollars from $5 to $100 notes

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Today is payday for eligible shareholders of mining giant Fortescue Metals Group Limited (ASX: FMG). This morning the company paid shareholders a fully franked interim dividend of $1.47 per share. Based on the latest Fortescue share price of $19.22, this represents a very generous 7.6% yield.

While some shareholders will be using this as a source of income, others may wish to invest it into the share market. If you're in the latter group, then you might want to consider one of these ASX shares. Here's why they are rated highly:

Altium Limited (ASX: ALU)

The first share to look at is Altium. It is a printed circuit board design software provider which has a leadership position in a market exposed to the Internet of Things and artificial intelligence. These two technologies are underpinning the proliferation of electronic devices globally, which is expected to lead to increasing demand for printed circuit board design software over the next decade.

Analysts at Morgan Stanley are positive on the company. So much so, they have an overweight rating and $37.00 price target on its shares. This compares to the latest Altium share price of $26.94.

Cochlear Limited (ASX: COH)

Another ASX share to consider investing these dividends into is Cochlear. It is one of the world's leading hearing solutions companies and has a very long track record of delivering solid earnings growth. And while the pandemic has been weighing on its performance, its strong first half result appears to show that the situation is easing. In light of this, the ageing populations tailwind, and its industry leading products, the future looks very bright for Cochlear.

Macquarie is a fan of the company. Last month its analysts put an outperform rating and $245.00 price target on its shares. This compares favourably to the current Cochlear share price of $213.15.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Altium. The Motley Fool Australia owns shares of Altium. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Growth Shares

3 monster stocks to hold for the next 3 years

These 3 ASX shares operate in different industries and could be worth holding for long-term growth over the next 3…

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

2 ASX growth shares to snap up while they're still down

Brokers see plenty of upside for these mainstay sector picks.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

Why these ASX growth stocks could be much bigger in 2030 than today

These stocks have long growth runways and strong business models.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Growth Shares

3 incredible ASX growth shares to buy and hold forever in 2026

True long-term investing means owning businesses you’d be happy to hold through volatility, uncertainty, and decades of change.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

2 shares to buy hand over fist before the ASX 200 soars higher in 2026

These shares are highly rated by brokers for a reason. Here's what you need to know about them.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Experts rate these 2 ASX shares as buys this month!

Leading analysts say these stocks are a buy.

Read more »

Happy healthcare workers in a labs
Technology Shares

Prediction: CSL shares could soar past $270 in 2026

Here's what to expect from the Australian-based global biotechnology company this year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

2 unstoppable ASX 200 stocks to buy in 2026 and hold forever

These blue chips could have very bright futures. Do you own them?

Read more »